Lewis-Hall Freda C
SEC insider (Form 3/4/5 filer). CIK 0001437909. Director at Helus Pharma Inc. (HELP) and 3 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Mar 24, 2026. Located in TORONTO.
Companies Lewis-Hall Freda C has filed insider reports for
- Helus Pharma Inc. (HELP): Director
- Pyxis Oncology, Inc. (PYXS): Director
- CONDUIT PHARMACEUTICALS INC. (CDT): Director
- SpringWorks Therapeutics, Inc. (SWTX): Director
Lewis-Hall Freda C
CIK: 0001437909
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Mar 24, 2026PYXS
Pyxis Oncology, Inc.
AwardDirectStock Option (Right to Buy)
45.9K shares- - Aug 12, 2025CDT
CDT Equity Inc.
AwardDirect35K shares- - Aug 5, 2025CDT
CDT Equity Inc.
AwardDirectStock Option (Right to Buy)
15K shares- - Jul 1, 2025SWTX
SpringWorks Therapeutics, Inc.
DispositionDirect24.7K shares- - May 14, 2025SWTX
SpringWorks Therapeutics, Inc.
AwardDirect10.1K shares- - Mar 31, 2025PYXS
Pyxis Oncology, Inc.
AwardDirectStock Option (Right to Buy)
37K shares at avg. $0.98- - Mar 30, 2025CDT
CONDUIT PHARMACEUTICALS INC.
AwardDirect47.6K shares at avg. $0.89$42K - Dec 18, 2024CDT
CONDUIT PHARMACEUTICALS INC.
AwardDirectStock Option (Right to Buy)
420K shares at avg. $0.07- - Nov 18, 2024CDT
CONDUIT PHARMACEUTICALS INC.
AwardDirect438K shares at avg. $0.09$40K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 24, 2026 |  PYXS Pyxis Oncology, Inc. | Award Stock Option (Right to Buy) | 45,867 | - | - | Direct |
| Aug 12, 2025 |  CDT CDT Equity Inc. | Award | 35,000 | - | - | Direct |
| Aug 5, 2025 | CDT CDT Equity Inc. | Award Stock Option (Right to Buy) | 15,000 | - | - | Direct |
| Jul 1, 2025 |  SWTX SpringWorks Therapeutics, Inc. | Disposition | 24,727 | - | - | Direct |
| May 14, 2025 | SWTX SpringWorks Therapeutics, Inc. | Award | 10,060 | - | - | Direct |
| Mar 31, 2025 | PYXS Pyxis Oncology, Inc. | Award Stock Option (Right to Buy) | 36,979 | $0.98 | - | Direct |
| Mar 30, 2025 | CDT CONDUIT PHARMACEUTICALS INC. | Award | 47,612 | $0.89 | $42,375 | Direct |
| Dec 18, 2024 | CDT CONDUIT PHARMACEUTICALS INC. | Award Stock Option (Right to Buy) | 420,000 | $0.07 | - | Direct |
| Nov 18, 2024 | CDT CONDUIT PHARMACEUTICALS INC. | Award | 437,976 | $0.09 | $40,250 | Direct |
1-9 of 9 transactions